• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全肺灌洗——技术细节、挑战及并发症处理

Whole lung lavage-technical details, challenges and management of complications.

作者信息

Awab Ahmed, Khan Muhammad S, Youness Houssein A

机构信息

University of Oklahoma Health Sciences Center, Pulmonary and Critical Care Section, Oklahoma, USA.

出版信息

J Thorac Dis. 2017 Jun;9(6):1697-1706. doi: 10.21037/jtd.2017.04.10.

DOI:10.21037/jtd.2017.04.10
PMID:28740686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5506114/
Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease characterized by alveolar accumulation of surfactant material with resulting hypoxemia and reduced lung function. Whole lung lavage (WLL) to physically remove the proteinaceous material from the affected lung is the standard treatment. Since its original description in 1964, there have been increasing numbers of WLL procedures done worldwide and the technique has been variously refined and modified. When done in experienced centers, WLL provides long lasting benefit in the majority of patients. It is considered safe and effective. There are no guidelines standardizing the procedure. Our preferred method is to lavage one lung at a time, with the patient supine, filling to functional residual capacity (FRC) and repeating cycles of drainage and instillation with chest percussion until the effluent is clear. The aim of this article is to provide a detailed description of the technique, equipment needed and logistic considerations as well as providing a physiologic rationale for each step of WLL. We will also review the available data concerning variations of the technique described in the literature.

摘要

肺泡蛋白沉积症(PAP)是一种罕见疾病,其特征为肺泡表面活性物质积聚,导致低氧血症和肺功能下降。通过全肺灌洗(WLL)从患肺中物理清除蛋白质物质是标准治疗方法。自1964年首次描述以来,全球范围内进行的WLL手术数量不断增加,该技术也得到了各种改进和改良。在经验丰富的中心进行时,WLL能为大多数患者带来持久益处。它被认为是安全有效的。目前尚无规范该手术的指南。我们首选的方法是让患者仰卧,每次灌洗一侧肺,灌至功能残气量(FRC),并重复进行引流和滴注循环,同时进行胸部叩击,直至流出液清澈。本文旨在详细描述该技术、所需设备和后勤考虑因素,并为WLL的每一步提供生理学依据。我们还将回顾文献中有关该技术变体的现有数据。

相似文献

1
Whole lung lavage-technical details, challenges and management of complications.全肺灌洗——技术细节、挑战及并发症处理
J Thorac Dis. 2017 Jun;9(6):1697-1706. doi: 10.21037/jtd.2017.04.10.
2
Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.肺泡蛋白沉积症的全肺灌洗治疗:当前实践与操作的全球调查
Orphanet J Rare Dis. 2016 Aug 31;11(1):115. doi: 10.1186/s13023-016-0497-9.
3
Management of primary pulmonary alveolar proteinosis: A multicentric experience.原发性肺泡蛋白沉积症的管理:一项多中心经验。
Lung India. 2020 Jul-Aug;37(4):304-309. doi: 10.4103/lungindia.lungindia_401_19.
4
How We Do It: Whole Lung Lavage.我们的做法:全肺灌洗。
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(2):e2022017. doi: 10.36141/svdld.v39i2.12884. Epub 2022 Jun 29.
5
Association between one-session bilateral whole-lung lavage and periprocedural complications in patients with pulmonary alveolar proteinosis: a retrospective cohort study.一次双侧全肺灌洗术与肺泡蛋白沉积症患者围手术期并发症的关系:一项回顾性队列研究。
Orphanet J Rare Dis. 2023 Apr 20;18(1):91. doi: 10.1186/s13023-023-02691-9.
6
Anesthetic management during whole-lung lavage using lung ultrasound in a patient with pulmonary alveolar proteinosis: a case report.肺泡蛋白沉积症患者全肺灌洗术中应用肺部超声的麻醉管理:一例报告
Yeungnam Univ J Med. 2021 Oct;38(4):374-380. doi: 10.12701/yujm.2021.01284. Epub 2021 Sep 6.
7
Efficacy of whole lung lavage in pulmonary alveolar proteinosis: a 20-year experience at a reference center in Thailand.全肺灌洗治疗肺泡蛋白沉积症的疗效:泰国一家参考中心的20年经验
J Thorac Dis. 2021 Jun;13(6):3539-3548. doi: 10.21037/jtd-20-3308.
8
Whole-lung Lavage and Pulmonary Alveolar Proteinosis: Review of Clinical and Patient-centered Outcomes.全肺灌洗与肺泡蛋白沉积症:临床与以患者为中心结局的综述。
J Cardiothorac Vasc Anesth. 2019 Sep;33(9):2453-2461. doi: 10.1053/j.jvca.2019.03.047. Epub 2019 Mar 28.
9
Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis.肺泡蛋白沉积症患者全肺灌洗后的长期持久获益
Eur Respir J. 2004 Apr;23(4):526-31. doi: 10.1183/09031936.04.00102704.
10
Whole Lung Lavage Treatment of Chinese Patients with Autoimmune Pulmonary Alveolar Proteinosis: A Retrospective Long-term Follow-up Study.中国自身免疫性肺泡蛋白沉积症患者的全肺灌洗治疗:一项回顾性长期随访研究
Chin Med J (Engl). 2015 Oct 20;128(20):2714-9. doi: 10.4103/0366-6999.167295.

引用本文的文献

1
Whole lung lavage in the setting of exogenous lipoid pneumonia.外源性类脂性肺炎患者的全肺灌洗术
Respir Med Case Rep. 2025 Jul 25;57:102274. doi: 10.1016/j.rmcr.2025.102274. eCollection 2025.
2
Breathing new life: Cutting-edge anesthetic strategies for whole lung lavage in pulmonary alveolar proteinosis.注入新活力:肺泡蛋白沉积症全肺灌洗的前沿麻醉策略
Saudi J Anaesth. 2025 Jul-Sep;19(3):400-402. doi: 10.4103/sja.sja_375_24. Epub 2025 Jun 16.
3
Summary for clinicians: ERS guidelines on pulmonary alveolar proteinosis.临床医生摘要:欧洲呼吸学会肺泡蛋白沉积症指南。
Breathe (Sheff). 2025 May 13;21(2):240224. doi: 10.1183/20734735.0224-2024. eCollection 2025 Apr.
4
Therapeutic Whole Lung Lavage for Pulmonary Alveolar Proteinosis: Technique With Continuous Video-Enabled Double Lumen Endotracheal Tube.治疗性全肺灌洗治疗肺泡蛋白沉积症:使用带连续视频功能的双腔气管导管的技术
Respirol Case Rep. 2025 Mar 18;13(3):e70153. doi: 10.1002/rcr2.70153. eCollection 2025 Mar.
5
Phenotypic heterogeneity in mortality and prognosis of pulmonary alveolar proteinosis: a large-scale, global pooled analysis of individual-level data.肺泡蛋白沉积症死亡率和预后的表型异质性:个体水平数据的大规模全球汇总分析
Orphanet J Rare Dis. 2025 Mar 4;20(1):102. doi: 10.1186/s13023-025-03617-3.
6
Long-term outcomes in five patients with autoimmune pulmonary alveolar proteinosis treated with molgramostim inhalation solution.五例接受莫拉司亭吸入溶液治疗的自身免疫性肺泡蛋白沉积症患者的长期预后
ERJ Open Res. 2025 Jan 27;11(1). doi: 10.1183/23120541.00567-2024. eCollection 2025 Jan.
7
Whole Lung Lavage in Autoimmune Pulmonary Alveolar Proteinosis: Unique Challenges in a Resource-Limited Setting.自身免疫性肺泡蛋白沉积症中的全肺灌洗:资源有限环境下的独特挑战
Clin Case Rep. 2024 Nov 18;12(11):e9588. doi: 10.1002/ccr3.9588. eCollection 2024 Nov.
8
A Comprehensive Outlook on Pulmonary Alveolar Proteinosis-A Review.肺肺泡蛋白沉积症的全面概述-综述。
Int J Mol Sci. 2024 Jun 28;25(13):7092. doi: 10.3390/ijms25137092.
9
Nebulised granulocyte-macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis.雾化粒细胞-巨噬细胞集落刺激因子(GM-CSF)治疗自身免疫性肺泡蛋白沉积症:系统评价和荟萃分析。
Eur Respir Rev. 2023 Nov 22;32(170). doi: 10.1183/16000617.0080-2023. Print 2023 Dec 31.
10
Alveolar macrophages in pulmonary alveolar proteinosis: origin, function, and therapeutic strategies.肺泡蛋白沉积症中的肺泡巨噬细胞:起源、功能和治疗策略。
Front Immunol. 2023 Jun 14;14:1195988. doi: 10.3389/fimmu.2023.1195988. eCollection 2023.

本文引用的文献

1
Efficacy of Whole-Lung Lavage in Pulmonary Alveolar Proteinosis: A Multicenter International Study of GELF.全肺灌洗治疗肺泡蛋白沉积症的疗效:一项关于GELF的多中心国际研究
Respiration. 2017;93(3):198-206. doi: 10.1159/000455179. Epub 2017 Jan 21.
2
Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures.肺泡蛋白沉积症的全肺灌洗治疗:当前实践与操作的全球调查
Orphanet J Rare Dis. 2016 Aug 31;11(1):115. doi: 10.1186/s13023-016-0497-9.
3
Therapeutic Whole-Lung Lavage for Pulmonary Alveolar Proteinosis: A Procedural Update.用于肺泡蛋白沉积症的治疗性全肺灌洗:操作更新
J Bronchology Interv Pulmonol. 2015 Jul;22(3):251-8. doi: 10.1097/LBR.0000000000000180.
4
Bilateral whole lung lavage in pulmonary alveolar proteinosis--a retrospective study.肺泡蛋白沉积症双侧全肺灌洗术——一项回顾性研究
Rev Port Pneumol. 2014 Sep-Oct;20(5):254-9. doi: 10.1016/j.rppneu.2014.04.004. Epub 2014 Jul 18.
5
British Thoracic Society guideline for diagnostic flexible bronchoscopy in adults: accredited by NICE.英国胸科学会成人诊断性可弯曲支气管镜检查指南:经英国国家卫生与临床优化研究所认可。
Thorax. 2013 Aug;68 Suppl 1:i1-i44. doi: 10.1136/thoraxjnl-2013-203618.
6
Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.抗栓治疗的围手术期管理:抗栓治疗与血栓预防,第 9 版:美国胸科医师学会循证临床实践指南。
Chest. 2012 Feb;141(2 Suppl):e326S-e350S. doi: 10.1378/chest.11-2298.
7
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Eur Respir Rev. 2011 Jun;20(120):98-107. doi: 10.1183/09059180.00001311.
8
Whole-lung lavage for pulmonary alveolar proteinosis.肺泡蛋白沉积症的全肺灌洗术
Chest. 2009 Dec;136(6):1678-1681. doi: 10.1378/chest.09-2295.
9
Therapeutic lung lavages in children and adults.儿童和成人的治疗性肺灌洗
Respir Res. 2005 Nov 22;6(1):138. doi: 10.1186/1465-9921-6-138.
10
The standard oxygen consumption value equivalent to one metabolic equivalent (3.5 ml/min/kg) is not appropriate for elderly people.相当于一个代谢当量(3.5毫升/分钟/千克)的标准耗氧量值并不适用于老年人。
Int J Food Sci Nutr. 2004 May;55(3):179-82. doi: 10.1080/09637480410001725201.